FBRX logo

FBRX

Forte Biosciences Inc.

$15.76
+$0.97(+6.56%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$153.30M
Volume
88.29K
52W Range
$4.11 - $28.68
Target Price
$63.33
Order:

Income Statement

MetricTrendChart
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$36.0K----------
Total Revenue
$36.0K----------
GROSS PROFIT
Gross Profit
$36.0K----------
OPERATING EXPENSES
Operating Expenses
$4.1M$46.3M$21.5M$13.9M$32.5M$36.6M
Research & Development
$2.7M$42.1M$13.9M$5.6M$21.9M$20.7M
Research Expense
$2.7M$42.1M$13.9M$5.6M$21.9M$20.7M
Selling, General & Administrative
$1.4M$4.2M$7.6M$8.3M$10.6M$15.4M
General & Administrative Expenses
$1.4M$4.2M$7.6M$8.3M$10.6M$15.4M
Salaries & Wages
--------$3.3M$3.1M
Depreciation & Amortization
$-843.0K----------
Depreciation & Amortization
$-843.0K----------
Other Operating Expenses
$-61.5M$52.0K$100.0K$19.0K$-94.0K$-160.0K
OPERATING INCOME
Operating income
$-4.1M$-46.3M$-21.5M$-13.9M$-32.5M$-36.6M
EBITDA
$-4.1M$-14.2M$-21.4M$-13.9M$-32.6M$-36.8M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$3.8M----$-162.0K$-1.1M$-1.3M
Intinc
$1.6M----------
Net Non-Operating Interest Income/Expense
$-2.3M----$-162.0K$1.1M$1.3M
Gain on Sale of Securities
$33.0K------$4.0K$7.0K
Other Income/Expense
$5.0K$205.0K$222.0K$-145.0K$114.0K$190.0K
Other Special Charges
$-5.0K$-205.0K$-222.0K$-145.0K$-114.0K$-190.0K
SPECIAL ITEMS
Restructring And Mn A Income
$-200.0K----------
Special Income Charges
$200.0K----------
Other Impairment Of Capital Assets
----$61.0K------
PRE-TAX INCOME
EBIT
$-4.1M$-14.2M$-21.5M$-13.9M$-32.6M$-36.8M
Pre-Tax Income
$-4.1M$-46.5M$-21.7M$-13.9M$-31.5M$-35.0M
INCOME TAX
Tax Provision
$1.0K$-3.2M$-67.0K$-79.0K--$-2.0K
NET INCOME
Net Income
$-4.1M$-46.5M$-21.7M$-13.9M$-31.5M$-35.5M
Net Income (Continuing Operations)
$-4.1M$-46.5M$-21.7M$-13.9M$-31.5M$-35.5M
Net Income (Discontinued Operations)
$-4.1M$-46.5M$-21.7M$-13.9M$-31.5M$-35.5M
Net Income (Common Stockholders)
$-4.1M$-46.5M$-21.7M$-13.9M$-31.5M$-35.5M
Normalized Income
$-3.2M$-49.8M$-21.7M----$-35.0M
TOTALS
Total Expenses
$4.1M$46.3M$21.5M$13.9M$32.5M$36.6M
SHARE & EPS DATA
Average Shares Outstanding
$945.2K$294.4K$558.7K$695.3K$1.3M$2.9M
Average Shares Outstanding (Diluted)
$945.2K$294.4K$558.7K$695.3K$1.3M$2.9M
Shares Outstanding
$956.0K$540.4K$590.5K$840.3K$1.5M$6.6M
Basic EPS
$-67.25$-158$-38.75$-20$-25$-12.17
Basic EPS (Continuing Operations)
$-67.25$-158$-38.75$-20$-25$-12.17
Diluted EPS
$-67.25$-158$-38.75$-20$-25$-12.17
Diluted EPS (Continuing Operations)
------$-20$-25$-12.17
OTHER METRICS
Gain On Sale Of P P E
$-1.2M----------
Other Gand A
$1.4M$4.2M$7.6M$8.3M$10.6M$15.4M
Realized Capital Gain
$1.4M----------
Restruct
$-200.0K----------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2FBRX$15.76+6.6%88.29K
3
4
5
6

Get Forte Biosciences Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.